RPT - INSIGHT-Safety concerns cloud early promise of powerful new cancer drugs
January 26, 2015 at 07:00 AM EST
NEW YORK, Jan 26 (Reuters) - A new wave of experimental cancer drugs that directly recruit the immune system's powerful T cells are proving to be immensely effective weapons against tumors, potentially transforming the $100 billion global market for drugs that fight the disease.
